IDP-023
Phase 1/2 Study of IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Filters
Save & Share
Clear Filters
Location
Explore options near your home - or near family and friends.
Diagnosis
Treatment History
Near Add Your Location
Sort by
University of Minnesota - Masonic Cancer Center
Minneapolis, MN
- Accepting patients
- Accepting patients
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsVirginia Cancer Specialists
Fairfax, VA
- Accepting patients
Weill Cornell
New York, NY
- Accepting patients
- Show Principal Investigator
- Accepting patients
Stanford University Cancer Institute (Palo Alto)
Stanford, CA
- Not yet accepting
- Not yet accepting
Lifespan Rhode Island Hospital
Providence, RI
- Not yet accepting
- Not yet accepting
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.